Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR3 | P49682 | 6/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12964746 | 0.77 | TSHR (0.32) | — | |
| SCHEMBL11513330 | 0.72 | — | — | |
| SCHEMBL29699608 | 0.69 | TSHR (0.44) | OPRM1OPRL1CYP2C19PDPK1MTOR | |
| SCHEMBL19598518 | 0.66 | OPRM1 (0.41) | OPRM1OPRL1MAPTCYP2C19PDPK1 | |
| SCHEMBL27260769 | 0.66 | TSHR (0.44) | OPRM1OPRL1CYP2C19PDPK1MTOR | |
| SCHEMBL15674250 | 0.65 | OPRM1 (0.40) | OPRM1OPRL1CYP19A1PDPK1MTOR | |
| SCHEMBL19580934 | 0.65 | OPRM1 (0.43) | OPRM1OPRL1CTSLCTSBCTSK | |
| SCHEMBL22341050 | 0.65 | CYP2C19 (0.41) | OPRM1OPRL1CYP2C19CTSLCTSB | |
| SCHEMBL11194228 | 0.65 | ALOX15 (0.36) | CYP19A1 | |
| SCHEMBL22594119 | 0.64 | OPRM1 (0.53) | OPRM1OPRL1CTSLCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006168-B2 | Odorant composition containing allyl ethers as odorant precursors | HENKEL AG & CO., KGAA (DE) | 2015-04-14 | — | — | US | disclosed |
| US-9006168-B2 | Odorant composition containing allyl ethers as odorant precursors | HENKEL AG & CO., KGAA (DE) | 2015-04-14 | — | — | US | disclosed |
| US-20140030397-A1 | ODORANT COMPOSITION CONTAINING ALLYL ETHERS AS ODORANT PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2014-01-30 | — | — | US | disclosed |
| US-20140030397-A1 | ODORANT COMPOSITION CONTAINING ALLYL ETHERS AS ODORANT PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2014-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140030397-A1 | ODORANT COMPOSITION CONTAINING ALLYL ETHERS AS ODORANT PRECURSORS | CHRM5, OR10J3, CHRM3 | CXCR3 902/4885OPRM1 83/4885OPRL1 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.